Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1993-10-15
1996-02-20
Kunz, Gary L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514921, A61K 3170, C07H 19167
Patent
active
054928982
ABSTRACT:
A method of treating mammals to reduce the deleterious effects of endotoxin and endotoxic shock mediators comprising administering a therapeutic amount of a 2-alkylthio-adenosine-5'-nucleotide. The preferred compound is 2-methylthio-adenosine-5'-triphosphate. The nucleotide used in this treatment inhibits lipopolysaccharide-induced GTPase activity.
REFERENCES:
patent: 3678162 (1972-07-01), Maguire et al.
patent: 4826823 (1989-05-01), Cook et al.
Lehninger, Albert L. "Biochemistry: The Molecular Basis for Cell Structure and Function", Second Edition. Worth Publishers, Inc. 1975, p. 218.
Gough et al. J. Med. Chem. 16(10):1188-1190, 1973.
Bertics Paul J.
Proctor Richard A.
Kunz Gary L.
Wisconsin Alumni Research Foundation
LandOfFree
Method of treating endotoxin effects with 2-methylthio-ATP and a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating endotoxin effects with 2-methylthio-ATP and a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating endotoxin effects with 2-methylthio-ATP and a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1355955